Kairos Pharma, Ltd. (KAPA)

Kairos Pharma, Ltd. (KAPA) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $2M; returns 1 day +2.7%, 1 week -7.1%, 1 year -92.7%.

Kairos Pharma, Ltd. (NYSE American: KAPA) is a clinical-stage biopharmaceutical company headquartered in Los Angeles, California, focused on the discovery and development of novel therapeutics for cancer patients. The company's primary focus is on addressing immune suppression and drug resistance in various cancers, including prostate, lung, breast, and glioblastoma.

Groups KAPA belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage
• Clinical Stage Biotech
• Oncology
• Biopharmaceutical
• Cancer Therapeutics
• Healthcare
• Pharmaceuticals
• Monoclonal Antibodies
• Drug Discovery
• Antibody Therapeutics
• Immunotherapy
• Life Sciences

KAPA financial model: income statement, cash flow and balance sheet